Authors:
PAUL C
TIDEFELT U
GRUBER A
LILIEMARK E
SUNDMANENGBERG B
JULIUSSON G
STENKE L
ELMHORNROSENBORG A
MOLLGARD L
LEHMANN S
COVELLI A
MALKHANDI J
GUSTAVSSON B
LILIEMARK J
Citation: C. Paul et al., THE P-GLYCOPROTEIN INHIBITOR (PGP) PSC-833 INCREASES THE INTRACELLULAR CONCENTRATIONS OF DAUNORUBICIN (DNR) IN-VIVO IN PATIENTS WITH PGP POSITIVE AML, Blood, 90(10), 1997, pp. 805-805
Authors:
LILIEMARK E
HERNGREN L
PETTERSSON B
PETERSON C
LILIEMARK J
Citation: E. Liliemark et al., ULTRAFILTRATION AND SUBSEQUENT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHYFOR IN-VIVO DETERMINATIONS OF THE PROTEIN-BINDING OF ETOPOSIDE, Cancer letters, 106(1), 1996, pp. 91-96
Authors:
LILIEMARK E
SODERHALL S
SIRZEA F
GRUBER A
OSBY E
BJORKHOLM M
ZHOU R
PETERSON C
LILIEMARK J
Citation: E. Liliemark et al., HIGHER IN-VIVO PROTEIN-BINDING OF ETOPOSIDE IN CHILDREN COMPARED WITHADULT CANCER-PATIENTS, Cancer letters, 106(1), 1996, pp. 97-100
Citation: Sas. Walles et al., DNA-DAMAGE INDUCED BY ETOPOSIDE - A COMPARISON OF 2 DIFFERENT METHODSFOR DETERMINATION OF STRAND BREAKS IN DNA, Cancer letters, 105(2), 1996, pp. 153-159
Citation: E. Liliemark et al., PROLONGED RETENTION OF ETOPOSIDE IN MDR1 EXPRESSING CELLS IN-VIVO BY TREATMENT WITH CYCLOSPORINE-A, Blood, 88(10), 1996, pp. 3321-3321
Authors:
LILIEMARK E
PETTERSSON B
PETERSON C
LILIEMARK J
Citation: E. Liliemark et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION FOR MONITORING OF ETOPOSIDE AND ITS CIS-ISOMER IN PLASMA AND LEUKEMIC-CELLS, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 311-317
Authors:
LILIEMARK E
SJOSTROM B
LILIEMARK J
PETERSON C
KALLBERG N
LARSSON BS
Citation: E. Liliemark et al., TARGETING OF TENIPOSIDE TO THE MONONUCLEAR PHAGOCYTIC SYSTEM (MPS) BYINCORPORATION IN LIPOSOMES AND SUBMICRON LIPID PARTICLES - AN AUTORADIOGRAPHIC STUDY IN MICE, Leukemia & lymphoma, 18(1-2), 1995, pp. 113-118
Authors:
GRUBER A
LILIEMARK E
TIDEFELT U
PAUL C
BJORKHOLM M
PETERSON C
LILIEMARK J
Citation: A. Gruber et al., PHARMACOKINETICS OF MITOXANTRONE, ETOPOSIDE AND CYTOSINE-ARABINOSIDE IN LEUKEMIC-CELLS DURING TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP TO TREATMENT OUTCOME AND BONE-MARROW TOXICITY, Leukemia research, 19(10), 1995, pp. 757-761
Authors:
LILIEMARK E
LILIEMARK J
KALLBERG N
BJORKHOLM M
SJOSTROM B
PETERSON C
Citation: E. Liliemark et al., STUDIES OF THE ORGAN DISTRIBUTION IN MICE OF TENIPOSIDE LIPOSOMES DESIGNED FOR TREATMENT OF DISEASES IN THE MONONUCLEAR PHAGOCYTIC SYSTEM, Pediatric research, 38(1), 1995, pp. 7-10
Authors:
LILIEMARK E
ZHOU R
LILIEMARK J
GRUBER A
WALLES S
Citation: E. Liliemark et al., DNA STRAND BREAKS INDUCED BY ETOPOSIDE AND THEIR RELATION TO CELLULARETOPOSIDE CONCENTRATIONS IN CEM-CELLS AND IN CELLS FROM PATIENTS WITHAML AND CLL, Blood, 86(10), 1995, pp. 3058-3058